Skip to main content

Role of structured individual patient education in the prevention of vascular complications in newly diagnosed type 2 diabetes: the INdividual Therapeutic Education in Newly Diagnosed type 2 diabetes (INTEND) randomized controlled trial

Endocrine volume 60, pages 46–49 (2018)Cite this article

Abstract

Objective

Recent studies showed that a structured patient therapeutic education (PTE) may decrease both mortality and the development of diabetes complications. Nevertheless, no data are available in the literature on the impact of individual PTE on the complications in newly diagnosed type 2 diabetic patients. Aim of the present randomized controlled trial is to evaluate the impact of individual PTE on the occurrence of macrovascular complications in newly diagnosed type 2 diabetic patients when compared to usual care (UC) and group PTE.

Design and methods

Six hundred newly diagnosed type 2 diabetic patients will be enrolled. The patients will be randomly assigned to one of these three groups: individual PTE, group PTE and UC. A comprehensive and complete PTE will be delivered to all the patients: PTE will include eleven themes. Primary composite endpoint of the study is occurrence of vascular complications, including cardiovascular death, non fatal coronary disease, non fatal stroke, peripheral artery disease. Secondary endpoints are: foot ulcers, amputations, sexual dysfunction, quality of life, microvascular complications, bone health, intensification of diabetes and hypertension therapy.

Results and Conclusions

The present trial can give precious information on the features for the most effective PTE.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. A. Coppola, L. Sasso, A. Bagnasco, A. Giustina, C. Gazzaruso, The role of patient education in the prevention and management of type 2 diabetes: an overview. Endocrine. 53, 18–27 (2016)

    CAS  Article  PubMed  Google Scholar 

  2. C.K. Wong, W.C. Wong, E.Y. Wan, A.K. Chan, F.W. Chan, C.L. Lam, Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP). Endocrine 53(2):412–422 (2016)

  3. X. He, J. Li, B. Wang, Q. Yao, L. Li, R. Song, X. Shi, J.A. Zhang, Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis. Endocrine 55(3), 712–731 (2017)

    CAS  Article  PubMed  Google Scholar 

  4. C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41(1), 89–95 (2012)

    CAS  Article  PubMed  Google Scholar 

  5. C. Gazzaruso, A. Pujia, S.B. Solerte, E.D. Amici, E. Emanuele, C. Falcone, D. Geroldi, A. Giustina, A. Garzaniti, Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int. J. Impot. Res. 18(3), 311–315 (2006)

    CAS  Article  PubMed  Google Scholar 

  6. C. Gazzaruso, A. Coppola, C. Falcone, C. Luppi, T. Montalcini, E. Baffero, P. Gallotti, A. Pujia, S.B. Solerte, G. Pelissero, A. Giustina, Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36(6), 1720–1725 (2013)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, A. Garzaniti, G. Pelissero, F. Salvucci, P. Gallotti, A. Pujia, C. Falcone, S.B. Solerte, A. Giustina, Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40(2), 273–279 (2011)

    CAS  Article  PubMed  Google Scholar 

  8. C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, G. Pelissero, S.B. Solerte, F. Salvucci, P. Gallotti, A. Pujia, A. Garzaniti, A. Giustina, Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients. Intern. Emerg. Med. 7(3), 257–266 (2012)

    Article  PubMed  Google Scholar 

  9. C. Gazzaruso, A. Garzaniti, P. Buscaglia, G. D’Annunzio, A. Porta, G. Vandelli, R. Lorini, G. Finardi, P. Fratino, D. Geroldi, Lipoprotein(a) levels and apolipoprotein(a) polymorphism in type 1 diabetes mellitus: relationships to microvascular and neurological complications. Acta Diabetol. 35(1), 13–18 (1998)

    CAS  Article  PubMed  Google Scholar 

  10. Questionario sullo stato di salute SF-36 (V1), Standard 12/94 IQOLA SF-36 Italian Version 1.6 http://crc.marionegri.it/qdv/downloads/SF36

  11. T. Montalcini, P. Gallotti, A. Coppola, V. Zambianchi, M. Fodaro, E. Galliera, M.G. Marazzi, S. Romeo, S. Giannini, M.M. Corsi Romanelli, A. Pujia, C. Gazzaruso, Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetes. Osteoporos. Int. 26(5), 1639–1646 (2015)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. S. Bossoni, G. Mazziotti, C. Gazzaruso, D. Martinelli, S. Orini, S.B. Solerte, G. Romanelli, A. Giustina, Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes. Age Ageing 37(2), 222–225 (2008)

    CAS  Article  PubMed  Google Scholar 

  13. C. Gazzaruso, M. Fodaro, A. Coppola, Structured therapeutic education in diabetes: is it time to re-write the chapter on the prevention of diabetic complications? Endocrine 53(2), 347–349 (2016)

    CAS  Article  PubMed  Google Scholar 

  14. S.P. Marso, G.H. Daniels, K. Brown-Frandsen, P. Kristensen, J.F. Mann, M.A. Nauck, S.E. Nissen, S. Pocock, N.R. Poulter, L.S. Ravn, W.M. Steinberg, M. Stockner, B. Zinman, R.M. Bergenstal, J.B. Buse, LEADER steering committee; LEADER trial investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. B. Zinman, C. Wanner, J.M. Lachin, D. Fitchett, E. Bluhmki, S. Hantel, M. Mattheus, T. Devins, O.E. Johansen, H.J. Woerle, U.C. Broedl, S.E. Inzucchi, EMPA-REG OUTCOME investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015)

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Diabetes and endocrine and metabolic diseases Unit and the Centre for Applied Clinical Research (Ce.R.C.A.) Clinical Institute “Beato Matteo” (Hospital Group San Donato), Vigevano, Italy

    Adriana Coppola & Carmine Gazzaruso

  2. Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy

    Livio Luzi

  3. Metabolism Research Center, IRCCS Policlinico San Donato, San Donato Milanese, Italy

    Livio Luzi

  4. Department of Clinical and Experimental Medicine, Nutrition Unit, University Magna Grecia, Catanzaro, Italy

    Tiziana Montalcini

  5. Chair of Endocrinology San Raffaele Vita-Salute University, Milan, Italy

    Andrea Giustina

Authors
  1. Adriana Coppola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Livio Luzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tiziana Montalcini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Giustina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carmine Gazzaruso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carmine Gazzaruso.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

The present trial complies with ethical requirements.

Informed consent

Informed consent will be required to any patient will be recruited.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Coppola, A., Luzi, L., Montalcini, T. et al. Role of structured individual patient education in the prevention of vascular complications in newly diagnosed type 2 diabetes: the INdividual Therapeutic Education in Newly Diagnosed type 2 diabetes (INTEND) randomized controlled trial. Endocrine 60, 46–49 (2018). https://doi.org/10.1007/s12020-017-1427-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-017-1427-x

Keywords

  • Diabetes
  • Patient education
  • Macrovascular complications
  • Self-management